1. Home
  2. Author: BioFactura

All posts by: BioFactura

About BioFactura

BioFactura (Frederick MD) develops and commercializes high-value biosimilars (i.e., follow-on biologics or generic biopharmaceuticals) using its patented StableFast Biomanufacturing Platform, the optimal system for bringing these drugs to market with faster, lower cost, superior-quality manufacture. For over 10 years, BioFactura has been advancing life-saving medicines from the research bench to the patient using its innovative drug development and manufacturing technologies. Current and past programs include biodefense drugs against smallpox and Ebola, novel medicines for cancer, and low-cost/high-quality biosimilars for autoimmune and infectious diseases.

BioFactura Announces Entry into Non-Exclusive License Agreement with Momenta Pharmaceuticals

BioFactura, Inc., an emerging Maryland biopharmaceutical research and manufacturing company, announced today entry into a non-exclusive license agreement with Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, relating to one of the biosimilar product candidates that Momenta is developing.  As part of this non-exclusive license agreement, … Continue reading

September 21, 2016 Press Releases

BioFactura Closes Oversubscribed $1.8M Series A Funding led by Chairman of the Board Dr. Jeffrey Hausfeld

BioFactura announced today the closing of a $1.8M Series A round of financing. Healthy investor interest drove significant oversubscription of the original $1.5M target. The funds will be used to advance a portfolio of generic biologics, known as biosimilars, to the advanced preclinical stages. Chief Executive Officer and President, Darryl Sampey founded BioFactura in 2004 as … Continue reading

April 26, 2016 Press Releases

Frederick biotech company gets praise to go with funding

From:  Frederick News-Post
By Nancy Lavin 07APR2016

The city of Frederick is putting its money where its mouth is in supporting the growing biotech industry. The Board of Aldermen on Thursday approved a $10,000 loan for BioFactura to support the company’s relocation and expansion. The city contribution will work in conjunction with a recently announced $50,000 loan from the Maryland Department of Commerce… Continue reading

April 7, 2016 In The News

BioFactura Announces the Appointment of Jeffrey N. Hausfeld MD, MBA as the Chairman of the Board and Chief Medical Officer

BioFactura proudly announces the appointment of Dr. Jeffrey Hausfeld as the newly elected Chairman of the Board and Chief Medical Officer. Dr. Hausfeld, a graduate from Yale University School of Medicine, practiced Otolaryngology and Facial Plastic Surgery in the Washington DC area for more than 23 years until he ventured into the business side of … Continue reading

September 17, 2015 Press Releases